Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers

Overview of attention for article published in American Journal of Hematology, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 36 X users

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 46 X posts from 36 X users, with an upper bound of 112,389 followers.

RT @DrAEvens: @CwynKate @UsuarezMD @graham74GC @AnnaSureda5 @tobyeyre82 @Lymphoma_Doc @LizSchorb 💯 regarding WBRT (ie, should be considered…

@CwynKate @UsuarezMD @graham74GC @AnnaSureda5 @tobyeyre82 @Lymphoma_Doc @LizSchorb 💯 regarding WBRT (ie, should be considered primarily palliative). However, there's caution re: ASCT. In RWD, <15% of older PCNSL receive consolidative ASCT (⬇️). IMH…

RT @DrAEvens: 🤔 If goal is curative intent (relatively speaking) or multi year remission, would consider careful renally dosed MTR (and wou…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 42 additional X posts.